This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffith, O. L. Articles by Wiseman, S. M. Search for Related Content PubMed PubMed Citation Articles by Griffith, O. L. Articles by Wiseman, S. M. Social Bookmarking                            What's this?

Meta-Analysis and Meta-Review of Thyroid Cancer Gene Expression Profiling Studies Identifies Important Diagnostic Biomarkers

Obi L. Griffith, Adrienne Melck, Steven J.M. Jones, Sam M. Wiseman

From the Michael Smith Genome Sciences Centre, British Columbia Cancer Agency; Departments of Medical Genetics and Surgery, University of British Columbia; Genetic Pathology Evaluation Center, Prostate Research Center of Vancouver General Hospital & British Columbia Cancer Agency; Department of Surgery, St Paul's Hospital, Vancouver, Canada

Address reprint requests to Sam M. Wiseman, MD, FRCSC, FACS, St Paul's Hospital, Room C302 Burrard Bldg, 1081 Burrard Street, Vancouver, BC, V6Z1Y6, Canada; smwiseman{at}providencehealth.bc.ca

Purpose An estimated 4% to 7% of the population will develop a clinically significant thyroid nodule during their lifetime. In many cases, preoperative diagnoses by needle biopsy are inconclusive. Thus, there is a clear need for improved diagnostic tests to distinguish malignant from benign thyroid tumors. The recent development of high-throughput molecular analytic techniques should allow the rapid evaluation of new diagnostic markers. However, researchers are faced with an overwhelming number of potential markers from numerous thyroid cancer expression profiling studies.

Materials and Methods To address this challenge, we have carried out a comprehensive meta-review of thyroid cancer biomarkers from 21 published studies. A gene ranking system that considers the number of comparisons in agreement, total number of samples, average fold-change and direction of change was devised.

Results We have observed that genes are consistently reported by multiple studies at a highly significant rate (P < .05). Comparison with a meta-analysis of studies reprocessed from raw data showed strong concordance with our method.

Conclusion Our approach represents a useful method for identifying consistent gene expression markers when raw data are unavailable. A review of the top 12 candidates revealed well known thyroid cancer markers such as MET, TFF3, SERPINA1, TIMP1, FN1, and TPO as well as relatively novel or uncharacterized genes such as TGFA, QPCT, CRABP1, FCGBP, EPS8 and PROS1. These candidates should help to develop a panel of markers with sufficient sensitivity and specificity for the diagnosis of thyroid tumors in a clinical setting.

Supported by the BC Cancer Foundation. Canadian Institutes of Health Research (O.L.G), the Natural Sciences and Engineering Council of Canada, and the Michael Smith Foundation for Health Research (S.J.M.J. and S.M.W.).

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Durand, C. Ferraro-Peyret, M. Joufre, A. Chave, F. Borson-Chazot, S. Selmi-Ruby, and B. Rousset Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features Endocr. Relat. Cancer, June 1, 2009; 16(2): 467 - 481. [Abstract] [Full Text] [PDF]

				M. R. Patel, P. C. Bryson, C. G. Shores, C. F. Hart, L. B. Thorne, A. M. Deal, and A. M. Zanation Trefoil Factor 3 Immunohistochemical Characterization of Follicular Thyroid Lesions From Tissue Microarray Arch Otolaryngol Head Neck Surg, June 1, 2009; 135(6): 590 - 596. [Abstract] [Full Text] [PDF]

				M. Xu, L. Shorts-Cary, A. J. Knox, B Kleinsmidt-DeMasters, K. Lillehei, and M. E. Wierman Epidermal Growth Factor Receptor Pathway Substrate 8 Is Overexpressed in Human Pituitary Tumors: Role in Proliferation and Survival Endocrinology, May 1, 2009; 150(5): 2064 - 2071. [Abstract] [Full Text] [PDF]

				R. C Smallridge, L. A Marlow, and J. A Copland Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies Endocr. Relat. Cancer, March 1, 2009; 16(1): 17 - 44. [Abstract] [Full Text] [PDF]

				S. M. Wiseman, A. Melck, H. Masoudi, F. Ghaidi, L. Goldstein, A. Gown, S. J. M. Jones, and O. L. Griffith Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis Ann. Surg. Oncol., October 1, 2008; 15(10): 2811 - 2826. [Abstract] [Full Text] [PDF]

				M. Eszlinger, K. Krohn, S. Hauptmann, H. Dralle, T. J. Giordano, and R. Paschke Perspectives for Improved and More Accurate Classification of Thyroid Epithelial Tumors J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3286 - 3294. [Abstract] [Full Text] [PDF]

				P. C. Bryson, C. G. Shores, C. Hart, L. Thorne, M. R. Patel, L. Richey, A. Farag, and A. M. Zanation Immunohistochemical Distinction of Follicular Thyroid Adenomas and Follicular Carcinomas Arch Otolaryngol Head Neck Surg, June 1, 2008; 134(6): 581 - 586. [Abstract] [Full Text] [PDF]

				N. B. Prasad, H. Somervell, R. P. Tufano, A. P.B. Dackiw, M. R. Marohn, J. A. Califano, Y. Wang, W. H. Westra, D. P. Clark, C. B. Umbricht, et al. Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors Clin. Cancer Res., June 1, 2008; 14(11): 3327 - 3337. [Abstract] [Full Text] [PDF]

				F. Weber and C. Eng Update on the Molecular Diagnosis of Endocrine Tumors: Toward -omics-Based Personalized Healthcare? J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1097 - 1104. [Abstract] [Full Text] [PDF]

				S. K. Chan, O. L. Griffith, I. T. Tai, and S. J.M. Jones Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 543 - 552. [Abstract] [Full Text] [PDF]

				W. H. Moretz III, C. G. Gourin, D. J. Terris, Z.-S. Xia, Z. Liu, P. M. Weinberger, E. Chin, and B.-L. Adam Detection of Papillary Thyroid Carcinoma With Serum Protein Profile Analysis Arch Otolaryngol Head Neck Surg, February 1, 2008; 134(2): 198 - 202. [Abstract] [Full Text] [PDF]

				K. Fujarewicz, M. Jarzab, M. Eszlinger, K. Krohn, R. Paschke, M. Oczko-Wojciechowska, M. Wiench, A. Kukulska, B. Jarzab, and A. Swierniak A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping Endocr. Relat. Cancer, September 1, 2007; 14(3): 809 - 826. [Abstract] [Full Text] [PDF]

				J. M. Cerutti, G. Oler, P. Michaluart Jr., R. Delcelo, R. M. Beaty, J. Shoemaker, and G. J. Riggins Molecular Profiling of Matched Samples Identifies Biomarkers of Papillary Thyroid Carcinoma Lymph Node Metastasis Cancer Res., August 15, 2007; 67(16): 7885 - 7892. [Abstract] [Full Text] [PDF]

				M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors Endocr. Rev., May 1, 2007; 28(3): 322 - 338. [Abstract] [Full Text] [PDF]